Senate probes alleged quid pro quo in Trump administration's easing of kratom and tobacco rules

Senate Finance Committee's top Democrat has opened an inquiry into recent policy changes affecting flavored vaping products and kratom, alleging the Trump administration softened regulations in exchange for campaign contributions.

The investigation targets President Trump's health secretary, Robert F. Kennedy Jr., as well as executives from Reynolds American and kratom producer Botanic Tonics, requesting written responses and documentation by the end of August.

Lawmakers claim the industries aim to expand sales of products that appeal to younger consumers, potentially increasing addiction risks, and accuse the administration of failing to protect public health.

The probe adds to broader concerns about corporate influence on health policy and could prompt further legislative action.